Systematic review of metformin monotherapy and dual therapy with sodium glucose co-transporter 2 inhibitor (SGLT-2) in treatment of type 2 diabetes mellitus [0.03%]
二甲双胍单药及与钠葡萄糖共转运体2抑制剂联合治疗2型糖尿病的系统评价
Nagashekhara Molugulu,Lai Shu Yee,Yew Tze Ye et al.
Nagashekhara Molugulu et al.
Background: Type 2 Diabetes Mellitus (T2DM) is a chronic disorder and its treatment with only metformin often does not provide optimum glycemic control. Addition of sodium glucose cotransporter 2 inhibitor (SGLT2) will im...
Predictive factors of developing type 2 diabetes mellitus, Acute Myocardial Infarction and stroke in a cohort with Impaired Fasting Glucose in Singapore [0.03%]
新加坡糖耐量减退队列中预测2型糖尿病、急性心肌梗死和卒中新因素的研究
Dennis Bingzhu Chia,Lai Yin Wong,Daveon Yu Kai Liu et al.
Dennis Bingzhu Chia et al.
Aims: This study describes the incidence and predictive factors for development of Type II Diabetes Mellitus (T2DM), Acute Myocardial Infarction (AMI) and stroke, among subjects with IFG over a five-year period. ...
CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents [0.03%]
CREED研究：三大洲的2型糖尿病患者在斋月期间的低血糖症状
Abdul Jabbar,Mohamed Hassanein,Salem A Beshyah et al.
Abdul Jabbar et al.
Aims: To describe diabetes treatment and hypoglycaemia in individuals with Type 2 diabetes mellitus during Ramadan. Methods: A multi-co...
Prevention of type 2 diabetes with the traditional Chinese patent medicine: A systematic review and meta-analysis [0.03%]
防治2型糖尿病的中成药：系统评价和荟萃分析
Bing Pang,Feng-Mei Lian,Xi-Yan Zhao et al.
Bing Pang et al.
Aim: Early interventions in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). The aim of this review was to assess the efficacy and safety of traditional Chinese patent medicine (TCPM) on ...
Alexandra Kautzky-Willer,Jürgen Harreiter
Alexandra Kautzky-Willer
Clinical guidelines for the management of type 2 diabetes recommend individual therapy considering age, duration of disease, presence of complication and risk of hypoglycaemia. However, at present, the patient's sex has no impact on clinica...
A self-assessment predictive model for type 2 diabetes or impaired fasting glycaemia derived from a population-based survey [0.03%]
基于人群的调查中建立的2型糖尿病和空腹血糖异常自我评估预测模型
Khairollah Asadollahi,Parisa Asadollahi,Monire Azizi et al.
Khairollah Asadollahi et al.
Aims: There is no cure for diabetes and its prevention is interesting for both people and health policy makers. The aim of this study was to construct a simple scoring system to predict diabetes and suggest a self assessm...
Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: Results from a randomized clinical trial [0.03%]
二甲双胍治疗可显著增强2型糖尿病患者的肠道葡萄糖吸收：一项随机临床试验的结果
Jukka P Koffert,Kirsi Mikkola,Kirsi A Virtanen et al.
Jukka P Koffert et al.
Aims: Metformin therapy is associated with diffuse intestinal 18F-fluoro-deoxyglucose (FDG) accumulation in clinical diagnostics using routine FDG-PET imaging. We aimed to study whether metformin induced glucose uptake in...
Randomized Controlled Trial
Diabetes research and clinical practice. 2017 Sep:131:208-216. DOI:10.1016/j.diabres.2017.07.015 2017
Effects of depression, diabetes distress, diabetes self-efficacy, and diabetes self-management on glycemic control among Chinese population with type 2 diabetes mellitus [0.03%]
抑郁症、糖尿病病耻感、自我效能和自我管理对我国2型糖尿病患者血糖控制的影响
Keke Lin,Chang Park,Mingzi Li et al.
Keke Lin et al.
Aim: To examine the direct and indirect effects of depression, diabetes distress, diabetes self-efficacy and diabetes self-management on glycemic control among a group of T2DM patients in China. ...
Efficacy and safety of empagliflozin in Japanese patients with type 2 diabetes mellitus: A sub-analysis by body mass index and age of pooled data from three clinical trials [0.03%]
恩格列净在中国2型糖尿病患者中的疗效和安全性：来自三项临床研究合并数据的BMI亚组分析和年龄探索性分析
Teruo Shiba,So Ishii,Tomoo Okamura et al.
Teruo Shiba et al.
Aims: To investigate the efficacy and safety of empagliflozin in subgroups based on body mass index (BMI) and age, using a pooled data set from Japanese patients with type 2 diabetes mellitus (T2DM). ...
Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T) [0.03%]
动态血糖监测在2型糖尿病治疗目标试验(4-T)中发现低血糖现象
J C Levy,M J Davies,R R Holman;-T Study Group
J C Levy
Aims: Hypoglycaemia is a significant risk in insulin treated type 2 diabetes and has been associated with future risk of cardiovascular events. We compared the frequency of low-glucose events using continuous glucose moni...